Po-Ren Hsiao

May 28, 2024 | jamanetwork.com | Po-Ren Hsiao |James Cheng-Chung Wei |Julie M. Paik |Helen Tesfaye

Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Nephrolithiasis in Clinical Practice SGLT2 Inhibitors and Nephrolithiasis Risk in Type 2 Diabetes Julie M. Paik, MD, ScD, MPH; Helen Tesfaye, PharmD, MSc; Gary C. Curhan, MD, ScD; Heidi Zakoul, BA; Deborah J. Wexler, MD, MSc; Elisabetta Patorno, MD, DrPH Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Nephrolithiasis in Clinical Practice—Reply Julie M.